Toshihiko Myojo Selected Research

Inflammation (Inflammations)

11/2016	Pulmonary responses in rat lungs after intratracheal instillation of 4 crystal forms of titanium dioxide nanoparticles.
1/2016	Comparison of pulmonary inflammatory responses following intratracheal instillation and inhalation of nanoparticles.
1/2015	Pulmonary toxicity of well-dispersed titanium dioxide nanoparticles following intratracheal instillation.
9/2013	Analysis of pulmonary surfactant in rat lungs after intratracheal instillation of short and long multi-walled carbon nanotubes.
1/2013	Comparison of dose-response relations between 4-week inhalation and intratracheal instillation of NiO nanoparticles using polimorphonuclear neutrophils in bronchoalveolar lavage fluid as a biomarker of pulmonary inflammation.
1/2011	Investigation of gene expression of MMP-2 and TIMP-2 mRNA in rat lung in inhaled nickel oxide and titanium dioxide nanoparticles.
6/2010	Expression of inflammation-related cytokines following intratracheal instillation of nickel oxide nanoparticles.
3/2010	Inflammogenic effect of well-characterized fullerenes in inhalation and intratracheal instillation studies.
10/2009	Expression of cytokine-induced neutrophil chemoattractant in rat lungs by intratracheal instillation of nickel oxide nanoparticles.
9/2009	Effect of polymerized toner on rat lung in chronic inhalation study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Toshihiko Myojo Research Topics

Disease

11	Inflammation (Inflammations) 11/2016 - 08/2009
7	Pneumonia (Pneumonitis) 01/2016 - 07/2007
5	Lung Injury 10/2014 - 03/2007
3	Fibrosis (Cirrhosis) 01/2011 - 09/2009
3	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2011 - 03/2007
1	Hypersensitivity (Allergy) 06/2010
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2010
1	Acute Lung Injury 01/2010

Drug/Important Bio-Agent (IBA)

5	nickel monoxide (nickel oxide)IBA 10/2014 - 08/2009
3	titanium dioxide (Titania)FDA Link 01/2015 - 08/2009
3	Silicon Dioxide (Silica)FDA LinkGeneric 10/2011 - 03/2007
2	CollagenIBA 11/2016 - 08/2009
2	Pulmonary Surfactants (Pulmonary Surfactant)IBA 01/2016 - 09/2013
2	CytokinesIBA 01/2016 - 06/2010
2	ChemokinesIBA 01/2015 - 10/2009
2	Biomarkers (Surrogate Marker)IBA 01/2013 - 01/2010
2	8-Hydroxy-2'-DeoxyguanosineIBA 01/2010 - 09/2009
1	Hematoxylin (Haematoxylon)IBA 11/2016
1	Rubber (Elastica)IBA 11/2016
1	Eosine Yellowish-(YS) (Eosin)IBA 11/2016
1	ceric oxide (cerium dioxide)IBA 01/2015
1	Phospholipids (Phosphatides)FDA LinkGeneric 09/2013
1	Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA 09/2013
1	Proteins (Proteins, Gene)FDA Link 09/2013
1	Heme Oxygenase-1IBA 01/2011
1	Matrix Metalloproteinases (MMPs)IBA 01/2011
1	AsbestosIBA 01/2011
1	Peptide Hydrolases (Proteases)FDA Link 01/2011
1	potassium octatitanateIBA 01/2011
1	CC ChemokinesIBA 06/2010
1	FullerenesIBA 03/2010
1	C-Reactive ProteinIBA 01/2010
1	Particulate MatterIBA 01/2010
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2010
1	RNA (Ribonucleic Acid)IBA 09/2009
1	Mineral Fibers (Mineral Fiber)IBA 07/2007
1	Calcitonin Gene-Related PeptideIBA 03/2007
1	Crocidolite Asbestos (Blue Asbestos)IBA 03/2007